Tessellate BIO Emerges from Stealth
The Next Generation Synthetic Lethality Precision Oncology Company
• The company aims to become a global leader in precision oncology by redefining Synthetic Lethality to treat large, currently unserved patient populations
• Lead program targets Alternative Lengthening of Telomeres (ALT) through the FANCM protein complex
• Company backed by leading venture firms, BioGeneration Ventures (BGV) and Forbion
• World-class leadership team with proven experience as entrepreneurs and deep expertise in drug discovery and precision oncology
Amsterdam, the Netherlands…
Bruntwood SciTech, the UK’s leading specialist property provider, founded by Legal & General and Bruntwood in 2018 to support the growth of the life science and tech sectors, has secured £500 million of additional investment and welcomed the UK’s largest local authority pension fund, Greater Manchester Pension Fund (GMPF), to the partnership. GMPF is the first local government pension scheme to make a direct and active investment into a UK-wide science, tech and innovation specialist property platform. The deal demonstrates the role that such funds can play in regenerating the UK’s towns…
Cambridge, UK, 13 October 2023, Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, congratulates its Chief Scientific Officer (CSO), David Rees PhD, FMedSci, FRSC on being honoured by the American Chemical Society (ACS) Heroes of Chemistry.
The award recognises researchers and companies for developing products that have led to significant advancements in improving health and the environment. The ceremony to honour these impressive achievements…
Phil Melia and R&D expert, Max Stanyard, delve into how recent R&D changes impact UK life sciences businesses.
The impact of R&D changes for UK life sciences - YouTube
• The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality novel chemistry leads on a second neurological disease target
Cambridge, UK and Tokyo, Japan, 10th October 2023 – PharmEnable Therapeutics, a UK drug discovery company, and Sosei Heptares (TSE: 4565), the international biopharmaceutical company, announce they have expanded their collaboration to apply their respective technologies to drive novel drug discovery for a second neurological disease target.
Sosei…
In the world of life science logistics, precision and reliability are paramount. John Roach, a Life Science Logistics Technician at Biocair with over 15 years of experience, shares his insights into this critical profession.
When you think of a patient needing life-saving medicine, we often hail the medical professional administering it as the hero. But, we overlook the important journey that medicine takes and who ensures it gets there. The role of a Life Science Logistics Technician goes far beyond just driving - they ensure that the most critical and urgently needed medicines reach their…
Howard Group strengthens team with appointment of Thomas Bewes as Asset Manager Surveyor joins Cambridge-based property investor and developer
Cambridge, 05 October 2022: Property investment and development company Howard Group is delighted to announce the appointment of Thomas Bewes MRICS as Asset Manager.
Thomas, a chartered surveyor, joins Howard Group from JLL, where he spent the last five years, most recently in the Industrial & Logistics Agency team, with responsibility for a portfolio of clients across Hertfordshire and East Anglia. Prior to joining JLL, Thomas studied at the…
London, October 5, 2023 – On Tuesday night, Kadans Science Partner won the 2023 category for best Refurbished/Recycled Workplace from the British Council for Offices’ (BCO). The BCO is Britain’s leading member organisation for leading, debating and discussing the office sector within the UK.
In June this year Sycamore House in Stevenage was the recipient of the Midlands and Central England region award within this category culminating in the national awards ceremony in London on the 3rd October.
The building was unanimously acclaimed by the judging panel for its transformation…
Optimizing Smooth Muscle Cell Cryopreservation for Cardiovascular Research
AMSBIO, in collaboration with the University of Strathclyde (UK), announce the release of a poster that describes a comprehensive assessment of the effects of three different cryopreservation reagents (CELLBANKER® 1, CELLBANKER® 2 and commonly used 10% DMSO) on the viability and proliferative capacity of vascular smooth muscle cells (vSMCs)
Central to understanding the vascular remodelling that underlies cardiovascular diseases is the ability to perform reliable single-cell analysis of vSMCs. Large-scale solutions for…
Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development
Nomination of novel drug target based on insights generated through application of Verily’s Immune Profiler platform and Sosei Heptares’ GPCR-focused structure-based drug design expertise
Tokyo, Japan, London and Cambridge, UK, 4 October 2023 – Sosei Group Corporation ("Sosei Heptares"; TSE: 4565) and Verily, an Alphabet precision health technology company, today announced the successful validation and nomination of a first G-protein-coupled receptor (GPCR) target into early drug…